AbSorber
Related
Latest news
-
2011-10-31
Clinical use of XM-ONE® was highlighted at a symposium at the annual American Society of Histocompatibility and Immunogetetics (ASHI) meeting in New Orleans -
2011-05-11
New study confirms that XM-ONE® identifies kidney transplant recipients at increased risk for acute rejection. -
2011-04-10
AbSorber to host a Scientific Symposium at the American Transplant Congress in Philadelphia, PA -
2011-02-10
AbSorber and Olerup SSP has signed an exclusive distribution agreement for the Brazilian market, the world's second largest transplantation market after the US. Partner in Brazil is Genese Produtos Diagnosticos Ltda in Sao Paulo.
Management
Anders Karlsson
CEO
Anders has extensive executive management experience within pharmaceutical companies. He has held several positions in marketing and sales in Sweden, and was previously CEO for Novartis’ operations in Norway.
Lars Öqvist
DIRECTOR Marketing
Lars has 20 years experience of the Pharmaceutical Industry and in depth knowledge in the area of Transplantation. He has held positions both in sales and marketing in many big Pharma companies, among them Novartis.
Håkan Hall
Head Research & Development
Håkan has a PhD in immunology from Karolinska Institutet and more than 10 years of experience in immunological research. He holds an MBA from Ted Rogers School of Management, Toronto, and has previously worked with sales, marketing and business development.
Ann-Cathrin Jareman, Head of QA and Regulatory Affairs
Ann-Cathrin has extensive experience in Regulatory Affairs and Quality Assurance from medical device as well as pharmaceutical industry. She was previously heading Linde Healthcare’s global regulatory affairs department.